News for Novavax, Inc. (NVAX)

Novavax, Inc. (NASDAQ:NVAX) TD Cowen 45th Annual Health Care Conference March 4, 2025 9:10 AM ETCompany ParticipantsJohn Jacobs - President and Chief...

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA)

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my post earnings update for NVAX stock.

Novavax Inc (NVAX) leverages cutting-edge technology to innovate in the vaccine industry.Strategic partnerships and global reach underscore the company's marke

Total Revenue: $682 million for the full year 2024.Product Sales: $190 million, primarily from US and European markets.Licensing, Royalties, and Other Revenue:

Feb 27, 2025 / 01:30PM GMTOperator Good morning and welcome to Novavax's 4th quarter 2024 Financial results and Operational highlights conference call. (Operato

Novavax Inc (NVAX), a biotechnology company known for its innovative vaccine solutions, announced on February 27, 2025, that its management team will participat

PR NewswireGAITHERSBURG, Md., Feb. 27, 2025 GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that the managem

NVAX reports encouraging fourth-quarter results. It completes the sale of its Czech Republic manufacturing unit to Novo Nordisk for $200 million.

Novavax, Inc. (NASDAQ:NVAX) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsLuis Sanay - Vice President, Investor...

Novavax (NVAX) delivered earnings and revenue surprises of 32% and 2.26%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

On February 27, 2025, Novavax Inc (NVAX) announced its financial results for the fourth quarter and full year of 2024, alongside strategic operational highlight

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells using the same gateway as the

HKU5-CoV-2 virus in China: After Covid-19 and HMPV, a new bat coronavirus discovered in China has sparked concerns among health officials and has triggered another pandemic fear. The newly discovered virus, however, is yet to be detected in humans. As per the researchers, this virus enters cells via the same receptor used by the Coronavirus that caused Covid-19.

Novavax (NVAX) closed the most recent trading day at $7.92, moving -1.25% from the previous trading session.

Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

On NVAX's fourth-quarter earnings call, investors will likely focus on updates on its pipeline.

Corporate America is trying to influence the new administration — and showcasing public displays of compliance with Trump’s agenda